Patent · US Revoked

Method for checking and controlling the mammalian lactic acid fermentation process/aerobic glucose fermentation metabolic pathway in mammalian organism

US10676777B2 · kind B2 · utility

0Cited by
0References
8Claims
0Family size

Inventor

Key dates

Filing dateMay 28, 2010
Grant dateJun 9, 2020
Priority date
Expiry dateApr 15, 2036

Classification

  • Technology area (CPC —)General

Abstract

The method for qualitative and quantitative detecting of the extend of use and the correct process flow of the mammalian aerobic glucose fermentation metabolic pathway (mam-aGF) in a mammalian individual is characterized in that the enzyme TKTL1 is used as indicator and target molecule and the structural and/or functional parameter of said TKTL1 in a biological sample of said individual (patient) are taken as indication for the qualitative and quantitative run of the mam-aGF in the cells and/or tissue of said individual (patient). In combination with the use of inhibitors and activators of the mam-aGF the method is further suitable for checking and controlling the mam-aGF in an individual (patient).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.